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Epidennal Langerhans cell heterogeneity is poorly 
understood with regard to phenotypic characteris-
tics, such as the expression of human leukocyte anti-
gen (HLA)-DR, integrin, and Fc receptor molecules, 
as well as functional characteristics, such as the 
ability to process and present antigens or produce 
cytokines during various phases of immigration and 
maturation. Technical limitations of Langer hans cell 
number have limited functional assays on putative 
Langerhans cell subsets in i" vivo epidermis. There-
fore, we used flow cytometry for simultaneous phe-
notypic and functional assessment at the single-cell 
level within the Langerhans cell population. Freshly 
isolated human epidermal cell suspensions were 
stained with a battery of monoclonal antibodies, 
including anti-HLA-DR, -CD la, -CDlc, -CDllc, 
-FcI'RII, and -FcERI. Two distinct Langerhans cell 
subsets were identified by their different levels of 
HLA-DR expression. The DRHi subset expressed 
higher amounts of CDl1c and exhibited greater cy-
toplasmic complexity and higher baseline calcium 
than the DRLo subset (p ::; 0.03 for each). Some 
subjects also expressed high levels of FCERI in the 
A ntigen-specific cutan eous immune responses are ini-tiated through the activation of epi.dermal and der-mal antigen-presenting cells (APCs) , whkh then induce T-cell proliferation and Iymphokine produc-tion . T he dendritic APC lineage population of nor-
mal epidermis, Langerhans cells [l ,2], are criti cal for the induction 
of primary immune responses agail1st contact allergens [3.4], al-
lografts [5], and chronic i.nflammatory skin diseases such as atopi c 
dermatitis [6J . Langerhans cells acquire a unique phenotypic and 
functional state upon loca lization within epidermis [6,7] and un-
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DRHi, CDllcHi subset. To determine whether these 
phenotypic subsets may exhibit differential signal-
transduction functional properties, Langerhans cells 
were partially enriched over Ficoll-Hypaque and 
their cytosolic calcium mobilization after the addi-
tion of ionomycin was analyzed using the calcium 
indicator, indo-1, in conjunction with quantitative 
analysis of HLA-DR expression. By this real-time 
flow cytometric analysis, a new subpopulation was 
revealed within the DR Lo Langerhans cell subset. 
This subset increased its cytosolic calcium concen-
tration much more than the other two subsets 
(change in indo-l blue:violet emission ratio of 37.33 
± 2.34 in the Hi Flux DRLo subset versus 13.23 ± 0.29 
in the Lo Flux DRLo subset, and versus 7.6 ± 2.99 in 
the Lo Flux DR Hi subset). These data indicate that 
functional, as well as phenotypic, subsets of Langer-
hans cells exist within nonnal human epidermis. 
Their responses to physiologic stimuli may relate to 
maturational stage or the level of ilt vivo activation. 
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dergo further modulation after stimulation with antigen, which 
includes emigration, enlargement, and phenotypic changes such as 
increased class n major hjstocompatibility complex (MHC) expres-
sion [8 -1 0] . Similarly to cultured Langerhans cells, ill "ill{) trigger-
ing of Langer hans cells also leads to a loss of the capacity to process 
native protein antigens and the acquisition of more potent antigen-
presenting capacity for restiJlg T cells [2,11 ,12]. Langerhans cell 
modulation is thought to be mediated at least in part by activated 
keratinocyte production of granulocyte macrophage colony-stimu-
lating factor [13] and tumor necrosis factor-a [14,15], or interleu-
kin-1/3 produced by the Langerhans cell population itself [16]. 
However, the key mechanisms causing Langerhans cell modulation 
remain to be resolved. . 
Cytosoljc calcium mobilization and production of dillcylglycerol 
induced by phosphatidyl i.nositol turnover act synergistically to 
activate protein kinase C (PKC) , a major signal transduction 
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pathway that links external sign als to in tracc llular cvcnts. Lan gcr-
hans cell s contain high amounts of PKC,B L 17 ,18] and app ear to 
have unde rgon c m o dulatio n through th is pathway in les ional 
p soriasis, as ev iden ced b y red uccd Lange rhans cell PKC,B [1 8] . T h e 
latte r finding pe rhap s accounts for t he lac k of th e activity of 
Langerh ans cells in a lloan t igen presentation b y les io n al epidermal 
cell s [1 9] . Furth er ill lIillo evide n cc that calc ium and phospho Lipid-
depe nde nt PKC is impo rtant for Langerhans cell function is pro-
vided by th e finding that ph ospha t idyl se rine enh ances contact 
sensitization in m ice [20] . T h c stu dy of La n gerhan s cell rcceptors 
and the fo llowing sign al transduc;tion cvcnts has b ecn h ampc red by 
the limi tcd numbe rs of Langerhans cell s availab lc fo r study and by 
the difl:i c ul ty of preparing tota lly pure samplcs of these cells. 
Howeve r, Langerh an s cell s can bc iso lated rcprodu cibly e lectron-
ica lly to extrem e ly high purity by Row cytomctry [21] , and sign al 
transdu ctio n involving cytosolic calcium m obilization also can bc 
visua lized in rea l time by this m eth od [22] . Mul t iparameter Row 
cytometry indeed a ll owed identification of distinct Lan gerhans cell 
subsets in some sa mples of hum an e pide rmis o n the b as is of both 
surface m arke rs and cytosolic calcium m obiliz atio n. 
MATEIUALS AND METHODS 
Antibodics Monoclonal antibody (MoAb) AEI"l..24 was used to detect 
express ion of the a subunit of hUlllan high-altinity IgE FceR..! rcceptor 
(FcElUa). · Othcr antibodies were purchased 1:;'0111 the fo llowing sources : 
phycoerythrin (PE)-conjugated MoAb to CO l a (T6-RD1) and PE-conju-
gated mouSc IgG l . Coul te r Immu nology (Hialeah. FL) : PE and biotin-
conjugatcd MoAb to human leukocyte antigcn (HLA)-DR, MoAb to 
CO li c (anti-Lcu-M5), and PE-conjugatcd mo usc IgG2a, Bccton Dickinson 
(Mounta in Vicw, CAl; MoAb to CO l a (OKT6) . O rtho Diagnostic Systems 
(Raritan, NJ) ; MoA b to FcyR.I1 (IV.3), Medarcx. Inc. (Annandale, NJ); 
M oAb to C O l c, Amac (Westbrook, ME); PE and flu o resccin isothiocyanate 
(F1TC)-conjugated goat anti-mo use IgG2b, Calrag Laboratorics Inc. (South 
San Francisco, CAl; FITC-conjugated goat anti- mo use IgG l , Boehringe r 
(Indianapo lis. IN) ; streptav idin conjugated with allophycocy:min , Bio lllcda 
Corpora tion (Foster City, CAl. Isotypc contro l mo usc antibodies were 
o bta ined fi'om Sigma Chemical Co. (St. Lo ui s. MO) and Phanningen (San 
Diego, CAl· 
EpidcrmaJ CclI Suspcnsions Ski n was obta ined from no rmal adu lt 
voluntcers by keratome biopsy after info rmcd consent, followed by over-
night incuba tion with Dispasc (50 U/m l) (Co ll aborativc Research. 
Wa ltham , MA) , as described [7]. Epidermal sheets were separated fi,om 
dermis, tr)'psinized , teased in to a cell suspension , and fi ltered thro ugh a 
nylon mesh to achicve a singlc-ce ll suspcnsion. Disaggrega ted cell s wcre 
resuspcnded with app ropriate media for thc fo llowing procedures. 
Quantification of Surfacc Antigcn Expression T he expression of 
surface antigens was IncaslIrcd by direct and indirect inlillUllofi uo [csccnce 
st:lining with the appropriate MoAbs, fo llowed by quantitative ana lysis by 
fl ow cytomctry. essentiall y as desc libed previously [8]. For all analytic 
experiments, epidermal cell suspensions wcre incubated with heat-aggre-
ga ted (65 °C X 20 min) puriflcd human IgG (Sigma) to block nonspecific 
binding of the MoAbs to the IgG Fc receptors. For double-marker 
fluoresccnce, PE-conjugated anti-HLA-DR was combined with appropriate 
primary antibodies and thcn incubatcd with FIT goat anti- mo use IgG l or 
IgG2b. For triplc- marker flu orescence. biotin-conjugated anti-HLA-D R 
was combined with two additional primary antibodies of difFerent isotypes, 
fo llowed by visua lization with streptavidin allo phycocyanin. PE goat anti-
mo usC IgG2b. and FITC goat anti-mOllse IgG l. Norma l human serum 
(10%) and no rmal goat serum (1 0%) were added at cach step to block 
nonspecific binding. 
CclJ Preparation for Cytosolic CaJcimn Measurcmcnt To o bt:Jin 
sufti cient flow rates of La nge rh :lll s cells fo r experimcnts measuring cytosolic 
ca lcium. epidcrmal cell suspensions wcre partially enriched in Langerhans 
cell s by Fico ll Aotation [21.23] . Epidermal cell suspcnsions were placed on 
the same vo lume of a Ficol l-Hypaque grad ient (Pharmacia. UppsaIa. 
Sweden) and ccntrifuged fo r 30 min at room tcmperature. Ccll s located at 
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thc interface were collected. resuspended at 1 X 10" cells/ml in phosphate-
bufFered sa line with 1% fctal bovinc serum contairilng 1 J.LM indo-1 AM 
(Molccular Probes, Eugenc, O R). and incubatcd in thc dark for 30 min at 
30°C . T his temperaturc was used to avoid possible dye compartmentaliza-
tion. Cell s were washed twicc in phosphate-bufFered saline with 1 % fetal 
bovine serum and thcn sta ined with PE-coltiugated anti-HLA-DR for 30 
min at room temperature. After washing, the cells were resuspended in the 
sa me buR'er and kept at room tempcrature until fl ow cytometric analysis. 
Cytosolic Calciulll Measurcmcnt Langerhans cell cytosolic calcium 
measurements were performed with an Epics Elite flow cytomcter. 
equipped with an air-cooled argon lascr for PE cxcitation at 488 rlm and an 
air-cooled ultraviolct laser for excitation of indo-l at 350 nm. Samples wcrc 
kcpt at 37°C using a circulating watcr bath during data acquisition. Changc 
of cytosolic calcium concentration was measured by calculating the ratio of 
the fl uorcsccnce intensities at two difFcrent cmission wavelengths, wlilch are 
at 405 nm (violet color) and 485 nm (bluc color). Indo-l shi fts the emission 
spectrum upon binding calcium (via increased calcium conccntration), and 
thus the emiss ion pcak at 405 n111 incrcases rcciprocally with a dccreasc in 
cmission at 485 nm . As a result, thc ratio of blue to violet fluoresccnce 
decreases as the calcium concentration increascs . Cells with inadcquate 
loading of dye wcrc cxcluded fro lll ana lysis by plotting b lue versus violet 
flu orescence intensity. Langerhans cell s in the suspensions were selected by 
visualizing thcir I-ILA-DK expression (PE flu orescence), and the cytosolic 
calc ium of this selected population was measured for 30 seconds before and 
210 seconds after thc addition of 10 J.LM calcium ionophore, ionomycin 
(Ca lbiochelll . La J olla , CAl. Changcs in calcium concen tration after 
stimulation were quantified eithcr as the raw blue:violet fluorcscencc 
intensity ratio or as the change (dclta) in bluc:violet ratio relativc to 
basel ine. All signa ls were stored in Listmode. down-loaded onto optical 
disks (M itsubishi), and analyzed using the Elitc software version 3 program 
(Coul ter) for DOS-based computers. 
Statistical Analysis T he mcan chan ncl fluorescence (MCF) intensity of 
Langerhans ccll markers and the blue:vio let ratio of indo-l fluorescence 
were co llcctcd in each individual subject, pooled for thc group mcan and 
standard error of thc mean (SEM) , an d compared using Student t test for 
paired data. 
RESULTS 
Identification of Two Langerhans Cell Subsets in Human 
Epidermis That Express Distinct Amounts of HLA-DR 
Upon the cxa mi n ation of Lan gerhan s cell HLA-DR e"-"Pression in 
conjunction with their cytoplasmic complexity (90 0 light scatter), a 
mino r but rcproducible Lan gerh ans cell subset could be identi.fied 
re lative to the isotype contro l stainin g (Fig 1). HLA-DR expres-
sio n of this minor Lan gerhans celJ subset (DRHi). which represents 
16.3 ::'::: 1.58% of Langer han s cells , was quite high (MCF ::'::: SEM = 
351 ::'::: 67.3) rela tive to the m ajor Lan gerh an s cell subset (DRI..O) 
(MCF ::'::: SEM = 66.2 ::'::: 16.3) (Table I) . Tn additio n . these two 
Lan gerh an s cell subsets d emonstrated distinct degrees of cytoplas-
mic complcxity; the DRHi subset contain ed m ore membrane-water 
interfaces th an did th e DR Lo subset (p = 0.030) (Table I). Because 
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Cytoplasmic C~mplexity CytoplasmiC Complexity 
Figurc 1. Langcrhans cclIs arc divisiblc into two distinct subscts 
b y thcir HLA-DR exprcssion and cytoplasmic cOlllplcxity. Cytoplas-
mic complexity (log 90° light scatter) of fres hly isolatcd epidermal cells is 
plotted vc rsus PE fluorescence intensity. LIft: isotypc control staining with 
PE-conjugatcd mouse IgG2a. R igh,: epidermal cells stained \vith PE-
conjugated anti- HLA-DR. A small Langcrhans cell subset intensely cx-
pressing HLA-DR (D K
"
';) is obscrvcd above the m'\ior HLA-DR + popu-
lation (DRLu ). 
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Table I. Phenotypic and Optical Characteristics of 
Resting Langerhans Cell Subsets" 
Percent of DR + 
DR intensity/' 
Cytoplasmic complexity' 
Baseline indo-1 e 
DIl~H 
16.3 :!: 1.58 
351 :!: 67.3 
9.05 :!: 2.31 
36 .4 :!: 3.08 
II Data represent average 2:: SEM; 11 = 1. 2. 
/, MCF ofHLA-DR sta ining. 
, Log 90° light scatter. 
DRLo 
83.7 :!: 1.58 
66.2 :!: 16.3 
5.81 :!: 1.19'/ 
47.0 :!: 1.59'/ 
d p = 0.03 (cycoplosmic complexity) and p = 0.01 (baseline indo-I). 
t' B:lsclinc ralio of bluc:violet fluorescence after indo-1 loading. 
cell size (forward light scatter) did not differ between the two 
subse ts (not shown), the high DR expression likely represents 
increased DR density, and the increased cytoplasmic complexity of 
the DR,-,i subset likely indicates increased surface membrane 
folding and/or cytoplasmic complexity [23J. Electron mi croscopy 
of purified subsets was not performed, but may be useful to 
characterize t1us finding further . 
Fc Receptor, {32 Integrin, and COl Expression on the DRLo 
and Hi Subsets Surface expression of FcylUI (n = 6), CDllc 
(n = 6), CDla (n = 5), Fc€lU (n = 3), and CDlc (n = 3) was 
quantified in each Langerhans cell subset in conjunction with 
HLA-DR quantification by double- or triple-color flow cytometry. 
In each of six subjects tested, the DRHi Langerhan s cell subset 
expressed higher amounts of CDllc (ax{32 integrin) than did the 
DR L o subset (p = 0:026) (Table II). In some individuals (two of 
six subjects), the DRHi subset expressed almost 10 times more 
CDllc than did the DR L o subset (Fig 2a). Thus, in such subjects, 
the DRHi , CDllcHi subset could be visualized on a dot plot as a 
compJetely separate cluster above and to the right of the main 
Langerhans cell population (Fig 2a). The increased CDl1c expres-
sion on the DR'-Ii Langerhans cells was not a finding common to all 
Langerhans cell surface markers because no such difference in 
surface staining was observed for CDla and FcyRII (Table II). 
However, more than two thirds of th e subj ects demonstrated a 
more subtle difference in CDllc (Fig 2c) . A similar distribution of 
subjects (one third) exhibited very high FCERI expression on the 
DRHi Langerhans cell subset (Fig 2b). CDlc, a marker for dendritic 
APC lineage in humans (7J, also demonstrated a trend toward 
higher expression in the DRHi subset, but this was not statistically 
significant (p = 0.11) . 
Langerhans Cell Subset Definition by the Ability to Mobi-
lize Cytosolic Calcium To determille whether these two 
Langerhans cell subsets differ in their flillctiona l attributes, we 
measured their capacity to mobilize cytosoli c calcium along with 
simultaneous HLA-DR quantification by multiparameter flow cy-
tometry. Langerhans cells were selected on the basis of their 
HLA-DR expression and visualized as PE fluorescence illtensity 
(Fig 3a). The DRHi subset was identified in this subject as a DR 
intensity of more than 600 fluorescence units (Fig 3a) . After gating 
on the DR + Langerhans cells (Fig 3") and acquiring the baseline 
indo-l fluorescence ratio ("pre") ionomycin was added to the 
sample and sampling flow resumed within 5 seconds (/,/"eak). As 
seen in Fig 3c, the DRHi Langerhans cell subset had a slightly lower 
baseline indo-l fluorescence ratio compared with the DRLo subset 
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(p = 0.01) (Table I). This difference in the baseline indo-l 
fluorescence ratio was seen in seven of eight different experiments 
(Table I). WitlUn 30 seconds of exposure to ionomycin, essentially 
all Langerhans cells exlubited a marked calcium increase (Fig 3"). 
However, two distinct patterns of calcium flux among Langerhans 
cells were observed. One Langerhans cell subset exhibited a brisk 
but moderate degree of calcium flux, reaching a blue:violet fluo-
rescence ratio of approximately 30, with some recovery thereafter 
(Fig 3"). The other subset exhibited an extreme degree of calcium 
mobilization, reaching a blue:violet fluorescence ratio of 12, with-
out evidence of recovery. These distinct subsets were seen in six of 
e ight different experiments (Fig 4) . 
To detennine whether the two Langerhans cell subsets defined 
by calcium mobilization were related to the phenotypically defined 
subsets, the indo-l blue:violet ratio before (Fig 3b, "pre") and after 
(Fig 3", "post") ionophore treatment was plotted against DR 
intensity. Before ionomycul exposure, the two Langerhans cell 
subsets of varying DR ultensity could be distinguished clearly (Fig 
3c, pre). By comparing the Langerhans cell blue:violet ratio to DR 
intensity after ionomycin exposure (Fig 3d, post), it is evident tha't 
the L3ngerhans cells that exlubited a marked degree of calcium flux 
represented mainly the DR Lo subset. However, only somewhat less 
than half of the DRLO subset demonstrated this extreme calcium-
flux phenotype. In contrast to the brisk illcrease of cytosolic 
calcium by the DR Lo subsets, the majority of DRHi Langerhans 
cells responded very weakly, with nUnunal calcium flux ulduced by 
the addition ofionomycin (Fig 3d, DR Hi) relative to their pretreat-
ment state (Fig 3c, DRHi). 
Thus, calcium mobilization capacity, combUled with DR expn;s-
sion, identifies three Langerhans cell subsets in normal human 
epidermis. Pooled data on these Langerhans cell ' subsets from 
multiple subjects are summarized in Table III. After stimulation 
with ionomycul, the Hi Flux DR Lo subset showed the lowest 
cytoplasmic complexity as well as the lowest DR ultensity and the 
lughest calcium mobilization capacity (delta blue:violet ratio). The 
La Flux DR Lo and the Lo Flux DRHi subsets had mid- and high 
cytoplasmic complexity, respectively (Table III). 
DISCUSSION 
This study indicates the presence of several Langerhans cell subsets 
that have not only phenotypic differences, but also distinct func-
tional and optica l properties. By multicolor surface staining, we 
could identify two distinct Langerhans cell subsets. These two 
subsets have differential expression of the class II MHC molecule, 
HLA-DR, and the {32 integrin, CDllc. Tlus difl:erence of surface 
marker expression was not due to nonspecific bUlding of MoAb, 
because the expression of other surf.,ce markers such as FcyRII and 
CDla was not different in these two subsets. A difference in cell size 
as the bas is for elevated DR and CDlic fluorescen ce per cell also 
was excluded because there was no difference Ul the forward light 
scatter between these subsets. Ovenught treatment with dispase at 
4°C may have modulatory effects on Langerhans cells, but the 
conclusion regarding differentially responsive subsets of Langer hans 
cells would still hold because each subset received the same 
treatment with dispase. The mea ning of distulct surface marker 
expression and functional responsiveness in Langerhans cell subsets 
is not yet clear, but may be related to particul ar states of differen-
tiation or focal recent ill. lIillo activa tion . 
Langerhans cells clearly can undergo maturational changes after 
external stimulation. Upon contact allergeri exposure in. 11;110 a.nd ill 
Table II. Expression of CDllc, COl Molecules, and Fc Receptors by Resting Langerhans Cell Subsets" 
CD11 c CD1a CD1c FclU FclUI 
DR~1i 29.8 :!: 8.55 197 :!: 53.9 32.9 :!: 10.2 2.06 :!: 0.382 34.3 :!: 9.88 
DRLo 12.7 :!: 4.69 182 :!: 24.2 16.3 :!: 3.72 1.69 :!: 0.507 30.2 :!: 5.79 
P value 0.026 0.87 0.11 0.47 0.94 
" Da ta represe nt average MC F ± SEM . 
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a b 
CD11c (PE fluorescence) FceRI (ATC fluorescence) 
c d 
. ' 
n ,.,r--, - ..,.....,-,.,..-,-rn"'''- r-T""TT 
1 n u. u .. 
CD11c (PE fluorescence) FceRI (FITC fluorescence) 
Figure 2. Range of patterns of DRHI Langerhans cell subset ex-
pression of CDllc and FceRI. Results are derived from two di1ferent 
individuals (subject 1 = n,b; subject 2 = c,d). nand c: electronically selected 
HLA-DR + epidermal cells (visualized as APC fluorescence) are co-stained 
with PE mouse IgG2b (colllo"I'plo(.<) or with PE anti-CDllb (dot plots). DR>'; 
Langerhans cells exhibi t moderate (c) to large (n) rightward shifts in PE 
fluorescence (relative to the isotype control contour plot), and are labeled 
DR>';, CDll CHi, whereas DR Lo Langerhans cells with less of a rightward 
shift in PE flu orescence are labeled DR La , CDllcLa . band d: HLA-DR + 
epidemlal ceils are costained with mouse IgGl (COIllO" I' plots) or anti-FcER! 
(dol plots). As with CDllc, some subjects exhibited a very large rightward 
shift in FcElU flu orescence intensity by their DR H, subset (b), whereas in 
other subjects the delta in FcElU MCF was similar in both the DRHi and 
DR La Langerhans cell subsets (d). 
/Jitra, Langerhans cells change their class II MHC antigen expression 
[8-10]. After short-teml culture, Langerhans cells alter their phe-
notypic properties upon removal from epidermis and/or in response 
to cytokin e exposure and become more similar to lymphoid 
dendritic ce lJs [2,24,25] . For example, human Langerhans cells 
increase their class II MHC antigen expression, and their expression 
of CD1a and FcrRII is decreased [24,25]. Thus, the DRHi , 
CDllcHi Langerh ans cell subset may represent a population that 
has exp el;enced recent ;1/. /J;/JO activation and commenced matura-
tional changes, but that has not emigrated from the epidermis. T lus 
con cept is supported further by the abili ty of chemoattractants to 
up-regulate CD11.c expression in m onocytes [26]. Because {32 
in tegrin s are connected to the cytoskeleton and fWlction as adhe-
sion molecules [27], variations in CD 1.1 c may regulate Langerhans 
cell morphology, function, or intraepiderm al position. On the other 
h and , the DRHi subset recently m ay have immigrated to the 
epidernus [1,28]. 
T here are severa l reports suggestin g the presence of Langerhans 
cell subsets in normal skin by flow cytometry [2,21,29,30]. Fur-
thermore, two Langerhans cell populations, determined by distinct 
levels of class II MHC antigen expression , em erged 24 h after 
epicutaneous application of the hapten trinitrochloroben zen e to 
naive mice [9]. T h ese reports are consistent with o ur results in 
humans demonstrating both constitutive phenotypic and fWlCtion-
ally e licited Langerhans cell subsets. In addition , we observed lug h 
expression of FceRI by th e DRHi , CD11cHi Langerhans cell subset 
in som e individuals. FceRI itself can trigger calcium flux upon 
external crosslinking in other cell types [31,32] and also can 
function to capture antigens for antigen presentation [33]. 
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Figure 3. Cytosolic calcium mobilization in HLA-DR+ epidermal 
cells after stimulation with ionomycin. HLA-DR + epidemlal cells 
were selected electronically (a); DR + epidermal cells were stimulated with 
ionomycin at 30 seconds (break), and the ratio of the two different emission 
wavelengths of indo-l was analyzed up to 4 min (b) . Cells before and 90 
seconds after ionomycin stimulation were selected (pre and post in b, 
respectively) and plotted by HLA-DR expression on the :.,' ax:is and indo-l 
ratio on the}' axis (c,d). DR Hi and DR La subsets were identified in DR + 
epidennal cells before ionomycil1 stimulation (c). After stimulation, the 
DR La subset was divided further into Hi Flux and Lo FhD': subsets (d). 
Elevations in b aseline cystolic calcium have been reported after 
surface receptor stimulation in other immunologic cell types [34]. 
Dilferential b aseline indo-1 fluorescence ratios between DRHi and 
DR Lo suggest tI,at ti,e DR Hi Langerh ans cell subset may represent 
Langerhans cells that have elevated their baseline cytosolic CalCiunl 
after recent endogenous stimulation by the surrowlding nUlieu, 
either as a result of h avin g recently traversed into tile epidermis or 
as a result of local intraepidennal perturbations. Differen tial indo-l 
fluorescence intensity as a result of n onw1iform loading, dye 
bleaching, or cell tluckness is avoided by using ratio analysis of the 
two enuss iol1 wavelengths of indo-1. 
We noted distinct calcium flux intensity levels in Langerhans cell 
subsets after addition of calcium ionophore . Again, we suspect that 
the DR Hi subset may have been activated recently ill 11;110, to 
account for its refractoriness to further calciu1111110bilization. These 
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Figure 4. Grouped data demonstrating the reproducibility of the 
differential response by Langerhans cells after ionomycin stimula-
tion. Low-responder and high-responder Langerhans cell subsets were 
observed in six of eight subjects. 
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Table III. Relation of Langerhans Cell Subsets, 
Identified by Elicited CalciUln Flux, to Class II MHC 
Expression and Cytoplasmic Complexity 
D R Cytoplasmic 
R atio" In tcnsity Complexity 
Hi Flux OR Lo 37.33 ± 2.34 1.00 2.53 ± 0.42 
Lo Flux DRlo 13.23 ± 0.29 1.1 9 ± 0 .03 5 .45 ± 2.64 
Lo Flux D R "; 7.60 ± 2 .99 6.54 :t 0.71 15.38 ± 8 .1 8 
" Ratio: the ratio ofbluc:violet fluorescence at the time of gate "pre" m_inus the ratio 
of blue:vio lc t Auorescence at the time of ga te "post." 
diiferentially respon sive Lan gerha ns cell subset s also exhibite d 
distin ct cytoplasmic complexity, p oss ibly b eca u se the subsets o f 
murine cla ss II M HC + e p id e rma l cells v ary ill d e n sity and c an 
ind u ce sen sitization or to le ran ce to antigen s (35]. We rule d out 
diffe re nti al compartm e nta liza ti o n of illdo -1 by assessing the p a t tem 
of h o m ogen eou s cytopl as m ic fl uo rescen ce b y fluorescen ce micros-
copy (data n ot sh o wn) . 
In summary, u sing multicolor flow cytom e try and simultaneou s 
ana lysis of su rface m a rke r exprcssio n ill conjunc ti o n w ith c al cium 
mobilizatio n , we iden tified phenotypica lly and fun c ti o n al1 y di stinc t 
Langerh an s cell s ubsets ill huma n e pidermis. P h e notypic ally, 
La n gerh an s ceBs w e re divide d into DRI-!; , C Dll c l-!; and DI~ Lo , 
CDllclo s ubse ts, whic h showe d di stinc t baseline c alcium levels 
a nd cytoplasmic com p lexi ty. Hig h expression o f FCEIU a nd CD l c 
also was a ssociated w it h the DRI-I;, C Dll c H ; subse t ill some 
su bj ects. Langerha n s .ce ll s ubsets wer e c h a racte ri zed fu rth er as Hi 
Flux DR LO, Lo F lux D R Lo, and Lo F lux DRI-I; subsets b y tne ir 
d istin ct resp onses to calcium io n o phore. T h ese d a ta indica te t h e 
p resen ce of multiple Lan gerh a n s cell subse ts w i thin human e pide r-
mis, w hic h m ay rep resent La n gerh a n s ceBs in di ffe re nt stages of 
activa ti o n , m aturation , a nd respo n siven ess to externa l m o dulatio n . 
T his lVork lVas SII)JJlorted ill pm1 by NIAMS gralll RD-l A R 41642-01A '1 (/lid 
U"i/wer COIporatio" a"d M"ltip"rpose A ,tl"ilis Cell /ergro,,! N IH ]>60 AR20557. 
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